Belararox is an emerging mineral exploration company focused on supporting the global electrification trend — from renewable energy and electric vehicles to advanced computing, AI infrastructure KPG Capital & CoJune 20, 2025
AltiBio is currently advancing several promising projects targeting an undisclosed rare disease KPG Capital & CoMay 18, 2025
At Alta Partners, trust is the cornerstone of all interactions, both internally and with external partners KPG Capital & CoMay 18, 2025
At the heart of Alloy Therapeutics is a mission to drive innovation in the biotechnology field KPG Capital & CoMay 18, 2025
Allosteric modulation involves influencing a protein’s function by binding to a site KPG Capital & CoMay 18, 2025
Alkeus’ lead molecule, gildeuretinol (ALK−001), has shown tremendous promise in addressing this critical issue KPG Capital & CoMay 18, 2025
At Alkermes, environmental responsibility is a core value that drives the company’s operations KPG Capital & CoMay 18, 2025
At the heart of Alexza’s product lineup is the Staccato® OBT™ system, an innovative drug delivery method KPG Capital & CoMay 18, 2025
Aleta Biotherapeutics’ CTEs address this challenge by enhancing the expression of CAR T KPG Capital & CoMay 18, 2025
Alcami provides a broad range of services tailored to meet the unique needs of its clients KPG Capital & CoMay 18, 2025
At the heart of Akttyva Therapeutics’ innovation is their proprietary AI−assisted platform, AIDE−360 KPG Capital & CoMay 18, 2025
Sensorineural hearing loss, which affects millions of individuals world wide, is caused by damage to the inner ear KPG Capital & CoMay 18, 2025
Akcea’s mission is to transform the treatment landscape for kidney disease by developing therapeutics KPG Capital & CoMay 18, 2025
Aisling Capital seeks out companies that are developing breakthrough technologies KPG Capital & CoMay 18, 2025
Airgas, Inc., a subsidiary of Air Liquide, is a leading U.S. supplier of industrial, medical, and specialty gases KPG Capital & CoMay 18, 2025
Agios prioritizes the growth and development of its employees by fostering a collaborative KPG Capital & CoMay 18, 2025
Agenus recently presented compelling survival data for the botensilimab and balstilimab combination KPG Capital & CoMay 18, 2025
Aer Therapeutics is committed to addressing the unmet needs of patients suffering from chronic respiratory conditions KPG Capital & CoMay 18, 2025
